Vemlidy

Vemlidy (tenofovir alafenamide) is an antiviral medication used to treat chronic hepatitis B virus (HBV) infection. It helps reduce viral load and supports liver health. This oral treatment is suitable for adults and may be prescribed alongside other therapies. Always follow healthcare provider guidance.

Vemlidy is primarily used to treat chronic hepatitis B virus (HBV) infection in adults. It works by reducing the amount of virus in the body, helping to improve liver function and lower the risk of complications. This medication is often prescribed for long-term management of HBV, including cases where the virus is actively replicating.

Vemlidy helps manage hepatitis B by lowering viral levels in the bloodstream. Users may notice improved liver function tests over time. Some individuals experience mild digestive effects, such as nausea or stomach discomfort, which typically resolve with continued use.

Vemlidy should be taken exactly as prescribed by a healthcare professional. Inform your doctor about any existing liver conditions or other medications you are taking. Regular monitoring of liver function and viral load is recommended during treatment to ensure effectiveness and safety.

Vemlidy may interact with other antiviral drugs, certain antibiotics, or medications that affect kidney function. Combining it with nephrotoxic agents could increase the risk of side effects. Always disclose all medications and supplements to your healthcare provider before starting treatment.